Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Postoperative Urinary Retention
NCT05753670Phase 3Completed
- Sponsor
- Endeavor Health
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamsulosin in postoperative urinary retention (POUR), sponsored by Endeavor Health. Started Jul 2023; status: completed.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT05753670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753670.